recombinant human endostatin
Sponsors
National Cancer Institute (NCI), University of Wisconsin, Madison, Chinese Academy of Sciences, Shanghai Jiao Tong University School of Medicine, Zhejiang Cancer Hospital
Conditions
Adenocarcinoma of LungBreast Cancer OrganoidsHead and Neck NeoplasmsHepatocellular CarcinomaLeptomeningeal MetastasisLung CancerMelanomaNon Small Cell Lung Cancer
Phase 1
Endostatin in Treating Patients With Advanced Solid Tumors
CompletedNCT00004229
Start: 1999-10-31Updated: 2013-02-11
Endostatin in Treating Patients With Advanced Refractory Solid Tumors
CompletedNCT00004872
Start: 2000-03-31Updated: 2019-12-13
Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC
CompletedNCT01733589
Start: 2012-11-30End: 2015-06-30Updated: 2017-07-14
Phase 2
Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
NCT02005120
Start: 2013-12-31End: 2015-12-31Target: 20Updated: 2013-12-20
Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.
NCT02350361
Start: 2014-01-31End: 2016-03-31Target: 60Updated: 2015-01-29
Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma
NCT03095079
Start: 2016-10-31End: 2018-10-31Target: 70Updated: 2017-03-29
Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)
NCT03208335
Start: 2017-01-01End: 2019-12-31Target: 61Updated: 2017-07-05
Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial Tumors
NCT03989830
Start: 2019-07-29End: 2022-06-30Target: 53Updated: 2020-10-23
Modified CV Regimen in Optic Pathway Glioma
RecruitingNCT05278715
Start: 2022-04-13End: 2025-12-31Target: 75Updated: 2024-10-15
Local Injection and Systemic Therapy in the Treatment of NSCLC.
Not yet recruitingNCT06618391
Start: 2024-10-08End: 2026-10-30Target: 84Updated: 2024-10-01
Phase 3
Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer
NCT00576914
Start: 2007-06-30End: 2012-06-30Target: 1108Updated: 2010-03-09
Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)
CompletedNCT01124253
Start: 2007-07-31End: 2009-10-31Updated: 2010-05-17
Phase 4
Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma
NCT02804646
Start: 2016-06-30End: 2018-12-31Target: 100Updated: 2016-06-21
Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
NCT04356118
Start: 2020-06-30End: 2023-06-30Target: 30Updated: 2020-05-27